Market capitalization | $13.55m |
Enterprise Value | $133.30m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.88 |
P/S ratio (TTM) P/S ratio | 0.19 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 7.49% |
Revenue (TTM) Revenue | $70.92m |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
3 Analysts have issued a Vapotherm, Inc. forecast:
3 Analysts have issued a Vapotherm, Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 71 71 |
7%
7%
|
|
Gross Profit | 33 33 |
66%
66%
|
|
EBITDA | -20 -20 |
62%
62%
|
EBIT (Operating Income) EBIT | -26 -26 |
57%
57%
|
Net Profit | -54 -54 |
32%
32%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. Its products include Precision Flow, Precision Flow Heliox, Oxygen Assist Module, Nitric Oxidie Disposable Patient Circuit, Tracheostomy Adapter, and Aerogen Adapter. The company was founded by William F. Niland, Jun Cortez, and William Cirksena in 1998 and is headquartered in Exeter, NH.
Head office | United States |
CEO | Joseph Army |
Employees | 207 |
Founded | 1998 |
Website | www.vapotherm.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.